Registry Study on Drug Therapy and Clinical Outcomes in Patients With Acute Coronary Syndrome

Not yet recruiting

• Conditions: Acute Coronary Syndrome; Drug Therapy

• Registration Number: NCT04184583
• Lead Sponsor: Beijing Anzhen Hospital

Brief Summary

Registry Study on Drug Therapy and Clinical Outcomes in Patients With Acute Coronary Syndrome

Detailed Description

Not available

Study Timeline

• Status Verified: 2019-11
• Study First Submitted: 2019-11-28
• Study First Submitted QC: 2019-11-29
• Last Update Submitted: 2019-11-29
• Study Start: 2019-12
• Study First Posted: 2019-12-03
• Last Update Posted: 2019-12-03
• Primary Completion: 2025-12
• Study Completion: 2026-12

Recruitment & Eligibility

• Status: NOT_YET_RECRUITING
• Sex: All
• Target Recruitment: 10000

Inclusion Criteria

• Informed consent has been signed.
• Patients diagnosed in our hospital with acute coronary syndrome.
• Age ≥18.
• Life expectancy ≥12 months.

Exclusion Criteria

• Severe lack of important information such as history of previous medication, history of previous disease, history of surgery.
• Pregnant and lactating women.
• Mental disorders, or inability to communicate effectively with researchers, or failure to comply with research protocols.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
main adverse cardiovascular and cerebrovascular events (MACCE)	up to 5 years	MACCE will be defined as all-cause death, non-fatal stroke, non-fatal myocardial infarction (MI), and ischemic-driven revascularization.

Secondary Outcome Measures

Name	Time	Method
Adverse drug reaction	up to 5 years	Adverse drug reaction will be defined as any adverse reactions in the patients.

Trial Locations

Locations (1)

Beijing Anzhen Hospital; 🇨🇳 Beijing, Beijing, China